Earnings Report: 6 Stocks Expected to Report Earnings Soon
September 18, 2023 (Earnings Report)Dear Reader,We just identified several stocks that are expected to release earnings very soon.If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments.Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Darden
Symbol: DRI
Recent Price: $150.06
Average Analyst Price Target: $171.60 (15.78%)
Market Cap: $18.14B
Last Year's EPS: 2.34
Consensus EPS Forecast: 2.54
Expected Earnings Date: 2023-06-22
Recent Analyst Action: Sara Senatore, analyst at Bank of America Securities, reiterates coverage on Darden (DRI) in the Consumer Cyclical sector with a Buy rating and a price target of $187 (2 days ago).
TipRanks.com also reports that Darden currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $171.60 . The target pricing ranges from a high forecast of $187 down to a low forecast of $160. Darden (DRI)’s last closing price was $150.06 which would put the average price target at 15.78% upside.Here are 3rd party ratings for DRI:
- TipRanks.com: Strong Buy
- TradingView.com:
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Top 24% (60 out of 252)
--------------------------------------------------------------------------
Factset Research
Symbol: FDS
Recent Price: $427.67
Average Analyst Price Target: $453.80 (0.57%)
Market Cap: $16.31B
Last Year's EPS: 3.38
Consensus EPS Forecast: 3.61
Expected Earnings Date: 2023-06-22
Recent Analyst Action: Seth Weber, analyst at Wells Fargo, reiterates coverage on Factset Research (FDS) in the Financial sector with a Hold rating and a price target of $435 (1 week ago).
TipRanks.com also reports that Factset Research currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $453.80 . The target pricing ranges from a high forecast of $480 down to a low forecast of $419. Factset Research (FDS)’s last closing price was $427.67 which would put the average price target at 0.57% upside.Here are 3rd party ratings for FDS:
- TipRanks.com: Hold
- TradingView.com:
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Buy, Top 44% (112 out of 252)
--------------------------------------------------------------------------
Manchester United
Symbol: MANU
Recent Price: $19.09
Average Analyst Price Target: $25.50 (33.58%)
Market Cap: $1.01B
Last Year's EPS: -0.07
Consensus EPS Forecast: 0.05
Expected Earnings Date: 2023-06-27
Recent Analyst Action: Randal Konik, analyst at Jefferies, reiterates coverage on Manchester United (MANU) in the Consumer Cyclical sector with a Buy rating and a price target of $26 (2 months ago).
TipRanks.com also reports that Manchester United currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $25.50 . The target pricing ranges from a high forecast of $26 down to a low forecast of $25. Manchester United (MANU)’s last closing price was $19.09 which would put the average price target at 33.58% upside.Here are 3rd party ratings for MANU:
- TipRanks.com: Moderate Buy
- TradingView.com:
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Bottom 23% (194 out of 252)
--------------------------------------------------------------------------
Valneva
Symbol: VALN
Recent Price: $14.17
Average Analyst Price Target: $19.33 (55.26%)
Market Cap: $932.82M
Last Year's EPS: -0.65
Consensus EPS Forecast: -0.35
Expected Earnings Date: 2023-05-04
Recent Analyst Action: Edward White, analyst at H.C. Wainwright, reiterates coverage on Valneva (VALN) in the Healthcare sector with a Buy rating and a price target of $22 (1 week ago).
TipRanks.com also reports that Valneva currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $19.33 . The target pricing ranges from a high forecast of $22 down to a low forecast of $16. Valneva (VALN)’s last closing price was $14.17 which would put the average price target at 55.26% upside.Here are 3rd party ratings for VALN:
- TipRanks.com: Moderate Buy
- TradingView.com:
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Top 29% (74 out of 252)
--------------------------------------------------------------------------
Thor Industries
Symbol: THO
Recent Price: $95.30
Average Analyst Price Target: $100.33 (12.28%)
Market Cap: $5.08B
Last Year's EPS: 0.5
Consensus EPS Forecast: 1.06
Expected Earnings Date: 2023-06-06
Recent Analyst Action: James Hardiman, analyst at Citi, reiterates coverage on Thor Industries (THO) in the Industrials sector with a Hold rating and a price target of $107 (2 weeks ago).
TipRanks.com also reports that Thor Industries currently has 3 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $100.33 . The target pricing ranges from a high forecast of $84 down to a low forecast of $107. Thor Industries (THO)’s last closing price was $95.30 which would put the average price target at 12.28% upside.Here are 3rd party ratings for THO:
- TipRanks.com: Hold
- TradingView.com:
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: Weak buy
- Zacks.com: Buy, Bottom 13% (220 out of 252)
--------------------------------------------------------------------------
Kintara Therapeutics
Symbol: KTRA
Recent Price: $4.16
Average Analyst Price Target: $14.00 (236.54%)
Market Cap: $7.27M
Last Year's EPS: -2.1
Consensus EPS Forecast: -0.1
Expected Earnings Date: 2023-05-11
Recent Analyst Action: Jason McCarthy, analyst at Maxim Group, reiterates coverage on Kintara Therapeutics (KTRA) in the Healthcare sector with a Buy rating and a price target of $14 (2 months ago).
TipRanks.com also reports that Kintara Therapeutics currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $14.00 . The target pricing ranges from a high forecast of $14 down to a low forecast of $14. Kintara Therapeutics (KTRA)’s last closing price was $4.16 which would put the average price target at 236.54% upside.Here are 3rd party ratings for KTRA:
- TipRanks.com: Moderate Buy
- TradingView.com:
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: hold
- Zacks.com: Hold, Top 37% (94 out of 252)
--------------------------------------------------------------------------
To Your Financial Future,
The Editor, WallStreetSectors.com